Fibrillation potential amplitude after denervation

Daniel Dumitru, John C. King

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Fibrillation potentials have been reported to decline in amplitude with time after denervation. The use of maximum fibrillation potential amplitude to determine the relative acuity of axonal loss ('old' v'new/recurrent') has been advocated but with conflicting endorsements as to the appropriate benchmark amplitude, i.e., 100 μV compared with 250 μV. This investigation uses computer simulations to examine the rate of fibrillation potential amplitude decline expected given known values for muscle fiber size atrophy and conduction velocity slowing over time after denervation. Factors that affect the amplitude and potentially lead to erroneous interpretations in the clinical scenario of partially denervated muscle tissue are discussed. The use of fibrillation potential maximum amplitude criteria to determine the age of lesion onset in both totally and partially denervated muscle is fraught with technical and pathophysiological hazards of interpretation and must be considered cautiously, if at all, in clinical practice.

Original languageEnglish (US)
Pages (from-to)483-489
Number of pages7
JournalAmerican Journal of Physical Medicine and Rehabilitation
Volume77
Issue number6
DOIs
StatePublished - Nov 1998

Fingerprint

Denervation
Muscles
Benchmarking
Age of Onset
Computer Simulation
Atrophy

Keywords

  • Denervation
  • Fibrillation Potential and Positive Sharp Waves
  • Muscle Atrophy
  • Nerve Injury
  • Simulation Studies

ASJC Scopus subject areas

  • Rehabilitation
  • Health Professions(all)
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Fibrillation potential amplitude after denervation. / Dumitru, Daniel; King, John C.

In: American Journal of Physical Medicine and Rehabilitation, Vol. 77, No. 6, 11.1998, p. 483-489.

Research output: Contribution to journalArticle

@article{6134ce5f67db4085ae7e7a75c6b64d0e,
title = "Fibrillation potential amplitude after denervation",
abstract = "Fibrillation potentials have been reported to decline in amplitude with time after denervation. The use of maximum fibrillation potential amplitude to determine the relative acuity of axonal loss ('old' v'new/recurrent') has been advocated but with conflicting endorsements as to the appropriate benchmark amplitude, i.e., 100 μV compared with 250 μV. This investigation uses computer simulations to examine the rate of fibrillation potential amplitude decline expected given known values for muscle fiber size atrophy and conduction velocity slowing over time after denervation. Factors that affect the amplitude and potentially lead to erroneous interpretations in the clinical scenario of partially denervated muscle tissue are discussed. The use of fibrillation potential maximum amplitude criteria to determine the age of lesion onset in both totally and partially denervated muscle is fraught with technical and pathophysiological hazards of interpretation and must be considered cautiously, if at all, in clinical practice.",
keywords = "Denervation, Fibrillation Potential and Positive Sharp Waves, Muscle Atrophy, Nerve Injury, Simulation Studies",
author = "Daniel Dumitru and King, {John C.}",
year = "1998",
month = "11",
doi = "10.1097/00002060-199811000-00005",
language = "English (US)",
volume = "77",
pages = "483--489",
journal = "American Journal of Physical Medicine and Rehabilitation",
issn = "0894-9115",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Fibrillation potential amplitude after denervation

AU - Dumitru, Daniel

AU - King, John C.

PY - 1998/11

Y1 - 1998/11

N2 - Fibrillation potentials have been reported to decline in amplitude with time after denervation. The use of maximum fibrillation potential amplitude to determine the relative acuity of axonal loss ('old' v'new/recurrent') has been advocated but with conflicting endorsements as to the appropriate benchmark amplitude, i.e., 100 μV compared with 250 μV. This investigation uses computer simulations to examine the rate of fibrillation potential amplitude decline expected given known values for muscle fiber size atrophy and conduction velocity slowing over time after denervation. Factors that affect the amplitude and potentially lead to erroneous interpretations in the clinical scenario of partially denervated muscle tissue are discussed. The use of fibrillation potential maximum amplitude criteria to determine the age of lesion onset in both totally and partially denervated muscle is fraught with technical and pathophysiological hazards of interpretation and must be considered cautiously, if at all, in clinical practice.

AB - Fibrillation potentials have been reported to decline in amplitude with time after denervation. The use of maximum fibrillation potential amplitude to determine the relative acuity of axonal loss ('old' v'new/recurrent') has been advocated but with conflicting endorsements as to the appropriate benchmark amplitude, i.e., 100 μV compared with 250 μV. This investigation uses computer simulations to examine the rate of fibrillation potential amplitude decline expected given known values for muscle fiber size atrophy and conduction velocity slowing over time after denervation. Factors that affect the amplitude and potentially lead to erroneous interpretations in the clinical scenario of partially denervated muscle tissue are discussed. The use of fibrillation potential maximum amplitude criteria to determine the age of lesion onset in both totally and partially denervated muscle is fraught with technical and pathophysiological hazards of interpretation and must be considered cautiously, if at all, in clinical practice.

KW - Denervation

KW - Fibrillation Potential and Positive Sharp Waves

KW - Muscle Atrophy

KW - Nerve Injury

KW - Simulation Studies

UR - http://www.scopus.com/inward/record.url?scp=0032214261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032214261&partnerID=8YFLogxK

U2 - 10.1097/00002060-199811000-00005

DO - 10.1097/00002060-199811000-00005

M3 - Article

C2 - 9862533

AN - SCOPUS:0032214261

VL - 77

SP - 483

EP - 489

JO - American Journal of Physical Medicine and Rehabilitation

JF - American Journal of Physical Medicine and Rehabilitation

SN - 0894-9115

IS - 6

ER -